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– In water tanks which cannot be emptied or controlled in-
troduce larvivorous fish (Gambusia).
– Weeds and tall gras around houses should be kept short.
– Use insecticides for water tanks which cannot be emp-
tied or inhabited with larvivorous fish.
Active surveillance by physicians using an appropriate
case definition should be established. This will facilitate
the detection of possible cases. Laboratory facilities for
rapid diagnosis and confirmation should be established
and continuously trained for diagnosing human cases.
Public health authorities should be on alert and prepared
for an outbreak organizing and training surveillance teams
and mosquito combating teams.
Relevance in travel medicine 
Many of the known endemic areas of Chikungunya
fever, like the islands of the Indian Ocean, India or
Malaysia and Indonesia are popular tourist destinations.
Therefore in a large number of travellers returning from
those countries an acute Chikungunya fever was diag-
nosed [4, 5, 6]. In a recent publication of a French Tropical
Medicine Department 121 human cases were reported
with more than half coming from Mauritius and about
10 % each returning from the Seychelles, from India and
from La Reunion [5]. Most cases were seen in France as
Mauritius and La Reunion are popular destinations for
French people [5]. From April 2005 to December 2006
about 900 human cases were diagnosed in travellers re-
turning from endemic and epidemic areas to France [10].
In a study at the Bundeswehr Institute of Microbiology in
Munich, Germany 11/192 (5.8 %) patients with fever and
additional constitutional symptoms returning from tropi-
cal areas were diagnosed with Chikungunya fever. In the
same patient population however 23/192 cases of acute
dengue fever were seen at the same time. 
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Laboratory testing relies on the good quality of sam-
ples. In case of Chikungunya virus the sample of choice is
serum. Physicians should notice as follows:
For isolation or detection of viral RNA, blood taken during
the first 7 days can be used. Best results are obtained dur-
ing the first five days of illness [13]. The blood should be
transported at 2 – 8 °C as fast as possible to the laboratory.
Do not freeze the blood. For longer transports (> 48 hours)
serum should be separated and transported on dry ice.
Serological detection of antibodies reliably works only af-
ter the first week of illness. 
For serological antibody detection blood should be trans-
ported at 2 – 8 °C. For longer transports (> 48 hours) serum
should be separated and can be frozen.
For serological detection of IgM antibodies ELISAor indi-
rect immunofluorescence can be used.
For serological detection of IgG antibodies ELISA or indi-
rect immunofluorescence can be used.  For the confirma-
tion of an acute infection a significant difference in titer in
paired sera is required.
For serological testing hemagglutination inhibition test
can be used. For the confirmation of an acute infection a
significant difference of titer in paired sera is required.
Cross reactions to other alphaviruses do occur in ELISA,
hemagglutination inhibition and indirect immunofluores-
cence.
Unspecific cross reactions have to be excluded by using a
neutralisation test.
Treatment
There is no specific treatment for Chikungunya fever.
Usually the illness is self limiting. Supportive care is indi-
cated according to the dominating symptoms. Movement
and mild exercise may improve stiffness and arthralgia
[13]. Non-steroidal anti-inflammatory drugs are used to
treat arthralgias [13]. Aspirin should be avoided due to its
potency of causing coagulation disorders. In arthritis
symptoms which do not respond to anti-inflammatory
drugs chloroquine can be useful. Life-threatening symp-
toms require admission in intensive-care units.
Prophylaxis, prevention and surveillance
There is currently no vaccine against Chikungunya
fever available. However, some candidate vaccines are un-
der study and especially various armed forces are interest-
ed due to the sudden potential loss of battle capacities dur-
ing an outbreak in the troops. Otherwise exposure prophy-
laxis at the moment is the only possibility of individual
protection. The individual exposure prophylaxis has to be
maintained the whole day as Aedes mosquitoes may be ac-
tive the whole day [8]. This includes:
– Wear long sleeves and pants.
– Use insect repellents containing a registered active in-
gredient on exposed skin.
– Use insecticide-treated bed-nets.
– Use mosquito-safe screens on windows and doors to
keep mosquitoes out.
– Sleep in acclimatised rooms or under insecticide-treated
bed nets.
For prevention of outbreaks the following measure
have to be taken:
– Control all water tanks, cisterns, barrels, trash containers
and use tight fitting lids.
– Remove or regularly empty all stagnant water sources in
and around houses.
Figure 2. Natural history of Chikungunya virus infection and time course for diagnostic procedures
Slika 2. Prirodni tijek Chikungunya virusne infekcije i vremenski slijed dijagnosti~kih postupaka
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maculopapular rash involving trunk and limbs and rarely
also face, palms and soles. Rarely petechiae are found.
During the acute infection most patients note medium
headache, photophobia and retro-orbital pain. Conjunctiv-
itis or conjunctival injections may also occur. Some pa-
tients complain of sore throat and pharyngitis.
Patients with milder symptoms are usually free of
symptoms within a few weeks. More severe cases require
months to resolve completely. According to some studies
up to 12 % of infections develop into a chronic form of
arthralgias which may persist for months to years [13]. The
cutaneous manifestations may fade or desquamate. Chi-
kungunya fever is usually not considered to be a life-threat-
ening disease. However, the very young and very old age
groups and immunsuppressed patients have a more severe
course of the disease. During the epidemic in La Reunion
more than 150 deaths were directly or indirectly associated
with Chikungunya fever. Meningo-encephalitis was an un-
common complication. The rare association with multi or-
gan failure is still under investigation. Thrombocytopenia
may occur and may also cause complications with intra-
vascular coagulation or intra-cerebral hemorrhage [9].
Laboratory diagnosis
The definite diagnosis of Chikungunya fever can only
be made by the laboratory. However Chikungunya fever
should be suspected in an epidemic situation in all human
cases fitting to a case definition. In a non-epidemic situa-
tion or with sporadic or imported cases the physician
should take into account this disease. An appropriate viro-
logical and/or serological testing should be done in all ar-
eas where Aedes albopictus and/or Aedes aegypti are pre-
valent and where cases with signs and symptoms that are
suggestive of Chikungunya fever occur.
The following case definition is used in countries with
endemic or epidemic occurrence of Chikungunya fever
[2]:
to mosquitoes of the genus Anopheles, the vectors of
malaria, mosquitoes of the genus Aedes usually are also
feeding during daylight hours. Transmission via blood do-
nations seems also possible, however it plays only a minor
role during en epidemic situation. Vertical maternal trans-
mission of Chikungunya virus has been observed in the re-
cent outbreak in La Reunion. During an epidemic situation
this kind of transmission also seems to be of minor impor-
tance.
Mosquitoes are mainly infected by sucking blood from
viremic patients. So far, the so-called mechanism of
transovarial transmission, the transmission from females
to their offspring has only been reported for Chikungunya
virus in the laboratory, but it seems to be of little impor-
tance during an epidemic for the maintenance of the virus
in mosquito population in nature. An urban transmission
cycle is defined as a cycle between humans as vertebrate
hosts and mosquitoes. In Africa and possibly in Southeast
Asia also a transmission cycle between mosquitoes and
monkeys as vertebrate hosts has been detected. This cycle
is named as sylvatic transmission cycle [10]. Human cases
of Chikungunya fever usually peak with the maximum of
mosquito populations during or at the end of the rainy sea-
son.
Chikungunya virus is endemic in areas of tropical
Africa and Asia. In Africa virus could be detected in west-
ern, central, eastern and southern Africa. The islands of the
eastern Indian Ocean seem to be epidemic, however at the
moment few or now cases are reported [11]. Therefore the
virus activity seems to be on halt. On the Indian subconti-
nent the Chikungunya outbreak seems to continue in sev-
eral states. Furthermore outbreaks continue to occur in
Malaysia and Indonesia [12]. The outbreak in September
2007 in Italy seems to be over. No new cases have been de-
tected or diagnosed in the affected region in 2008.
Clinical symptoms and pathogenesis
The incubation time of Chikungunya fever is on aver-
age 4 – 8 days, ranging from 2 to 12 days. The onset of clin-
ical symptoms is abrupt with high fever which rises up to
40 °C accompanied by intermittent chills and joint pain.
The acute phase lasts for 2 – 3 days. Then the temperature
may remit for 1– 2 days after a gap of 4 to 10 days, result-
ing in a typical saddle back fever curve. Constitutional
symptoms are headache, back pain, myalgia and, as a
prominent symptom, intense arthralgia. The arthralgias are
polyarticular, migratory and predominantly affect the
small joints of extremities (hands, ankles, wrists, pha-
langes) and, on a lesser extend also the larger joints. Swell-
ing of the affected joints may occur but fluid accumulation
is uncommon [13].
Cutaneous manifestations are typical. Many patients
present with a flush over the face and trunk, followed by a
Suspected case:
Acute illness characterized by sudden onset of fever with one
or several of the following symptoms: joint pain, headache,
backache, photophobia, arthralgia, rash occurring in an area
known to be endemic for Chikungunya fever or in an area
where Aedes aegypti or Aedes albopictus are prevalent
Probable case:
As above and positive serology (when a single serum is ob-
tained during the acute or convalescent phase)
Confirmed case:
A probable case with either:
Asignificant (minimum fourfold) IgG antibody difference in
paired serum samples
Detection of IgM antibodies 
Isolation of virus from the serum of the patient
Detection of Chikungunya virus RNA in sera by RT-PCR
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few years due to two events: in 2004 a large outbreak start-
ed in Kenya, east Africa and moved via the Comoros
Islands, the Island La Reunion (266,000 cases out of
750,000 inhabitants) and other islands on the southwest
Indian Ocean to reach India in 2005/2006, where a large
outbreak occurred (estimated 1,400,000 patients). This
current outbreak continues to spread and large numbers of
patients are still seen in parts of India, Indonesia and
Malaysia [3]. During this outbreak hundreds of travellers
from industrialized countries with a temperate climate be-
came infected with Chikungunya virus and returned home
while being viremic [4]. Many strains of the virus could be
isolated from such patients and the virus could be first iso-
lated form travellers returning to France [5, 6]. During this
outbreak it was recognized that the current strain circulat-
ing on the islands of the Indian Ocean better adapted to an-
other mosquito species, the Asian tiger mosquito, Aedes
albopictus, which was found highly prevalent and which
efficiently transmitted the virus between humans.
Additional concern among virologists and epidemiolo-
gists in Europe was raised by two events: an autochtho-
nous transmission of the virus to a nurse in France, and a
recent outbreak at Ravenna, in the North-east part of Italy,
very close to a popular touristic area [7]. This is thought to
be the first outbreak of a tropical human arboviral disease
in modern times in Central Europe. However, introduction
and sporadic cases of Chikungunya fever were already re-
ported in 1987 from Albania near Lake Skutari and it was
thought that migrating birds from Africa had introduced
the virus there. It should also be remembered that the last
Figure 1. Known global distribution of Chikungunya fever
Slika 1. Globalna rasprostranjenost Chikungunya groznice poznata do sada
big Dengue fever epidemic in the Mediterranean dates
back to 1928, a time when Aedes aegypti was still highly
prevalent in many areas of the Mediterranean coast re-
gions.
The current outbreak of Chikungunya fever in Italy
could be traced back to a traveller returning from India
(Kerala) in a viremic state and it was favoured by the diffu-
sion of Aedes albopictus in the affected area in Italy [7].
Aedes albopictus turned out to be an effective transmitter
of the virus between humans. It was introduced in the
1990s into the Mediterranean region and spread over total
Italy and to parts of France and Spain and to parts of the
eastern Adriatic coast (Croatia, Albania, Greece). All to-
gether Aedes albopictus is currently endemic in 12 Euro-
pean countries [8]. There are now concerns of a wider
spread of Chikungunya fever and fears of an endemic or
even epidemic situation like in the islands of the Indian
Ocean, India and Southeast Asia some years ago. The fol-
lowing paper will provide a review on various aspects of
Chikungunya fever emphasizing the practical approach
for an early detection in order to start prompt measure to
control the spread of this infection.
Transmission and Epidemiology
Chikungunya virus is most commonly transmitted to
humans through the bite of mosquitoes. Main vectors of
the virus are mosquitoes of the genus Aedes, mainly the
species Aedes aegypti and Aedes albopictus [9]. In contrast
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Chikungunya fever is a virus infection caused by a virus of the genus Alpha-
virus, family Togaviridae. It is transmitted in nature exclusively by mosquitoes
of the genus Aedes. It causes a febrile illness with prominent arthritis and inca-
pacitating arthralgias, which may last for months. In 2004, a large outbreak
started in East Africa, spread over India to Southeast Asia and caused an esti-
mated several million human cases in the affected countries. In 2007,
Chikungunya virus was introduced by a viremic traveller into Italy and there
caused an outbreak with more than 200 human cases. The virus there was trans-
mitted by the Asian tiger mosquito (Aedes albopictus). Chikungunya virus in
combination with Aedes albopictus forms a complex with high potential for
emergence in so far unaffected regions. The actual paper reviews the current sit-
uation and presents a case definition for detection of clinically suspicious cases
for rapid intervention of transmission.
Chikungunya groznica – invazivni tropski virus u mediteranskoj regiji?
Pregledni ~lanak
Chikungunya groznica je virusna infekcija koju uzrokuje virus roda Alphavirus,
iz obitelji Togaviridae. U prirodi se prenosi isklju~ivo komarcima roda Aedes.
Uzrokuje febrilnu bolest s izra`enim artritisom i artralgijama koje mogu trajati i
do nekoliko mjeseci. Godine 2004., zabilje`ena je velika epidemija u isto~noj
Africi koja se pro{irila preko Indije do jugoisto~ne Azije, uzrokuju}i, prema
procjenama, zarazu nekoliko milijuna stanovnika zahva}enih zemalja. Godine
2007., Chikungunya virus je unesen u Italiju preko zara`enog putnika uzroku-
ju}i epidemiju sa vi{e od 200 zara`enih osoba. Virus je tamo prenio azijski ti-
grasti komarac (Aedes albopictus). Chikungunya virus u kombinaciji sa Aedes
albopictus ~ini cjelinu s visokim potencijalom za pojavljivanjem u do sada
nezahva}enim podru~jima. U radu se donosi pregled trenutne situacije i defini-
raju kriteriji za otkrivanje klini~ki suspektnih slu~ajeva koji zahtijevaju brzu in-
tervenciju.
Introduction
Chikungunya fever is an infection caused by Chikun-
gunya virus, a so-called arbovirus (arthropod-borne virus)
which is transmitted to humans by the bite of mosquitos of
the genus Aedes. The name is derived from the African
Makonde dialect and means »that which bends up«. In ref-
erence to the stooped posture developed as a result of the
arthritic symptoms of the disease. The disease itself seems
to be an old one and probably was seen in human popula-
tion since centuries. However there was probably a lot of
confusion with dengue fever and other unspecific viral dis-
eases.
Chikungunya virus was first isolated in Tanganyika
(Tanzania) in 1953 from the serum of a febrile human [1].
In the following years and decades the virus was isolated
numerous times in central, southern and western Africa
and in many parts of south-eastern Asia and of the Indian
subcontinent. Since its first isolation and identification,
Chikungunya virus has caused uncountable outbreaks and
epidemics in both Africa and Asia involving hundreds of
thousands of people [2].
While until few years ago Chikungunya fever was
mainly in the minds of some tropical virologists and travel
medicine specialists this disease came to the attention of a
broad scientific and medical community during the last
